Home
Marksans Pharma Ltd EPS

Marksans Pharma Ltd
NSE: MARKSANS
EPS
Key Highlights
- The Earning per Share of Marksans Pharma Ltd is ₹ 8.13 as of 21 Feb 25 .
- The earning per share of Marksans Pharma Ltd changed from ₹ 1.52 to ₹ 2.31 over 7 quarters. This represents a CAGR of 27.02% .
Historical Earning per Share of Marksans Pharma Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Marksans Pharma Ltd
Company Fundamentals for Marksans Pharma Ltd
Market Cap
10,246 Cr
EPS
8.1
P/E Ratio (TTM)
27.8
P/B Ratio (TTM)
4.5
Day’s High
236.4
Day’s Low
224.5
DTE
0.1
ROE
15.2
52 Week High
358.5
52 Week Low
126.05
ROCE
19.0
Market Price of Marksans Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 226.1 |
20 Feb 2025 | 232.4 |
19 Feb 2025 | 227.9 |
18 Feb 2025 | 241.05 |
17 Feb 2025 | 238.45 |
14 Feb 2025 | 230.6 |
13 Feb 2025 | 249.5 |
12 Feb 2025 | 253.8 |
11 Feb 2025 | 251.45 |
10 Feb 2025 | 267.4 |
SWOT Analysis Of Marksans Pharma Ltd
BlinkX Score for Marksans Pharma Ltd
Asset Value vs Market Value of Marksans Pharma Ltd
Market Value
₹ 10,246
Asset Value
Value addition
4.5 X
₹ 1,854
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Marksans Pharma Ltd | 10246 | 8.13 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
Marksans Pharma Ltd | 10246 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of Marksans Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Marksans Pharma Ltd
Historical Revenue of Marksans Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Marksans Pharma Ltd
Historical EBITDA of Marksans Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Marksans Pharma Ltd
Historical Net Profit of Marksans Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Marksans Pharma Ltd
Dividend Payout Over Time
Marksans Pharma Ltd News Hub
Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketing Authoriz
Read more
21 Aug 24
Marksans Pharma gets EIR from USFDA for Goa facility
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
20 Aug 24
Marksans Pharma's Verna unit successfully completes USFDA inspection
Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR) for its
Read more
20 Aug 24
Marksans Pharma to convene AGM
Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 24 Se
Read more
20 Aug 24